Hudson Valley Investment Advisors Inc Bristol Myers Squibb CO Transaction History
Hudson Valley Investment Advisors Inc
- $813 Million
- Q2 2024
A detailed history of Hudson Valley Investment Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 15,426 shares of BMY stock, worth $832,386. This represents 0.08% of its overall portfolio holdings.
Number of Shares
15,426
Previous 14,035
9.91%
Holding current value
$832,386
Previous $761,000
15.9%
% of portfolio
0.08%
Previous 0.09%
Shares
28 transactions
Others Institutions Holding BMY
# of Institutions
2,407Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.56 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.93 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.03 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.19 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...